Alpha‐Fetoprotein Is a Potential Biomarker for Pancreatic Ductal Adenocarcinoma ( PDAC ): A Case Report
Open Access
- 22 April 2026
- journal article
- case report
- Published by Wiley in Cancer Reports
- Vol. 9 (4) , e70547
Abstract
Introduction: Pancreatic ductal adenocarcinoma (PDAC) is often diagnosed at an advanced stage, with high rates of mortality and drug resistance. Carbohydrate antigen 19‐9 (CA19‐9) is a tumor biomarker for diagnosis and prognosis in PDAC. However, elevated alpha‐fetoprotein (AFP) is exceedingly rare in the PDAC patient. Case Presentation: Herein, we describe a 67‐year‐old woman who presented with elevated AFP before the diagnosis of PDAC. In March 2025, this patient who had elevated AFP and CA19‐9 levels and was presenting with jaundice, was diagnosed with PDAC. Subsequently, she underwent pancreaticoduodenectomy, partial resection of the superior mesenteric vein (SMV), and SMV reconstruction. After radical resection (R0), the levels of AFP and CA19‐9 were significantly decreased. Next, she was treated with adjuvant chemotherapy (gemcitabine plus capecitabine). After four cycles of treatment, the patient presented with diarrhea, weight loss, poor nutritional status, and other signs of poor tolerance to chemotherapy. Thus, the regimen was changed to pembrolizumab plus trametinib. Hepatic recurrence was detected at the 7‐month follow‐up. At 11 months after surgery, the patient developed a biliary tract infection and obstructive jaundice, and ultimately died. Conclusions: This case demonstrates that AFP may be a potential biomarker for PDAC, especially in the CA19‐9‐negative PDAC patient.Keywords
Funding Information
- Shenzhen Research Foundation (JCYJ20220530145200001)
- Shenzhen Research Foundation (JCYJ20240813150252047)
- Guangdong Medical Research Foundation (A2023384)
- Basic and Applied Basic Research Foundation of Guangdong Province (2023A1515220088)
This publication has 36 references indexed in Scilit:
- Biology and significance of alpha‐fetoprotein in hepatocellular carcinomaLiver International, 2019
- A Patient With an Elevated α-Fetoprotein Level and Liver MassesJAMA, 2019
- Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomesWorld Journal of Gastroenterology, 2018
- Pancreatic acinar cell carcinoma—case report and literature reviewBMC Cancer, 2018
- Primary Hepatoid Carcinoma of the Pancreas: A Clinicopathological Study of 3 Cases With Review of Additional 31 Cases in the LiteratureInternational Journal of Surgical Pathology, 2018
- [Alpha-fetoprotein-producing pancreatic cancer: a case report].2017
- An Unusual Case of an Extremely Large α-Fetoprotein–Producing TumorGastroenterology, 2016
- Hepatoid carcinoma of the pancreas with lymphoid stroma: first description of the clinical, morphological, immunohistochemical, and molecular characteristics of an unusual pancreatic carcinomaVirchows Archiv, 2015
- CA19-9 serum levels in obstructive jaundice: clinical value in benign and malignant conditionsThe American Journal of Surgery, 2009
- Alpha-fetoprotein-positive adenocarcinoma of the pancreasInternational journal of pancreatology, 1989